SK Bioscience (302440 KS): Core Vaccines Gaining Traction; COVID Vaccine Gets International Approval
SK Bioscience recorded 5% YoY growth in core vaccine revenue in 1Q23, driven by shingles vaccine, SKY Zoster. Last month, the company received...
302 Views
Index Rebalance & ETF Flow Recap: HSCI, GDXJ, KRX New Deal, AMFI, Amman Mineral, Infratil
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
497 Views
KRX New Deal Index Rebalance Preview: A Change for Each Index
There is 1 change currently for each of the Secondary Battery, Bio, Internet & Game indices. There are some close contests among the top 3 stocks...
470 Views
Korea: What Are Foreign Investors Buying & Selling?
Foreign investors have been buying stock in Korea and hold 32% of the KOSPI market cap and 8.5% of the KOSDAQ market cap. There is a big dispersion...
462 Views
KRX New Deal Index Rebalance Preview: Potential & Close Changes in September
There were big moves on stocks that were changes at the March rebalance. We take a look at expected and close changes at the September rebalance....
614 Views